Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
http://www.sciencedaily.com/releases/2012/01/120112134326.htm
http://www.sciencedaily.com/releases/2012/01/120112134326.htm